Congress Asset Management »

iShares Dow Jones US Pharm Indx shares owned by Congress Asset Management

Quarter-by-quarter ownership of iShares Dow Jones US Pharm Indx (IHE) shares owned by Congress Asset Management from 13F filings

Historical chart of Congress Asset Management investment in iShares Dow Jones US Pharm Indx

Tip: Access up to 7 years of quarterly data

All positions including iShares Dow Jones US Pharm Indx held by Congress Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares Dow Jones US Pharm Indx by Congress Asset Management

Quarter filed Position value Share count Share price at filing
2026-09-30 $56k 56k 1.00

More positions owned by Congress Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Halozyme Therapeutics (HALO)
Arista Networks (ANET)
Ligand Pharmaceuticals In (LGND)
Facebook Inc cl a (META)
Repligen Corporation (RGEN)
Visa (V)
Amazon (AMZN)
Costco Wholesale Corporation (COST)
Amphenol Corporation (APH)
Mongodb Inc. Class A (MDB)

View all positions for Congress Asset Management

Top funds holding iShares Dow Jones US Pharm Indx

Fisher Investments
Bank of America Corporation
Jpmorgan Chase & Co
LPL Financial
TD Asset Management
Goldman Sachs Group
Royal Bank of Canada
Insight Wealth Strategies
UBS Group
Wells Fargo & Company
Brown Advisory Holdings Incorporated
Raymond James Financial
Congress Asset Management
Bnp Paribas Arbitrage, Snc
Concurrent Investment Advisors

View all funds holding iShares Dow Jones US Pharm Indx